By: Healthcare Dive Editorial Staff
Date: November 13, 2026
In a decisive move to safeguard the integrity of the Medicare program, the Centers for Medicare & Medicaid Services (CMS) has announced a six-month extension of the national moratorium on the enrollment of new home health agencies and hospices. The pause, which will now remain in effect through June 13, 2027, underscores the federal government’s deepening anxiety regarding systemic fraud, aggressive billing practices, and the oversight challenges posed by the rapid consolidation of the post-acute care sector.
While the extension signals a continued "get-tough" approach by federal regulators, the agency has introduced a critical modification to the existing policy. Unlike the initial moratorium implemented in May, established providers will now be permitted to open new practice locations, a pivot aimed at balancing the necessity of fraud prevention with the practical requirement of ensuring patient access to care.
The Core Mandate: Why the Moratorium Persists
The CMS’s decision to extend the freeze is rooted in a persistent pattern of exploitation within the home health and hospice industries. Despite initial efforts to curb illicit activity, federal investigators have identified that these sectors remain highly susceptible to "bad actors"—entities that infiltrate the Medicare system to submit fraudulent claims for services that are either medically unnecessary or never rendered.
The primary goal of the extension is to provide the CMS with a longer runway to scrutinize enrollment applications, conduct intensive background checks, and refine its ability to detect "shell" organizations. By halting the influx of new providers, the agency aims to prevent the proliferation of fraudulent networks that often emerge as quickly as they are dismantled.
Key Regulatory Components:
- Fingerprint-Based Background Checks: The CMS will maintain its requirement for mandatory, intensive fingerprint-based screening for operators and owners.
- Enhanced Enrollment Screening: All applicants face rigorous vetting processes designed to verify the legitimacy of the business structure and the credentials of the personnel involved.
- Pre- and Post-Claim Review: The agency will continue its practice of reviewing claims both before and after payment to identify anomalous billing patterns—a hallmark of organized fraud.
A Shift in the Landscape: Private Equity and Ownership Volatility
A significant driver of this regulatory scrutiny is the changing ownership landscape within healthcare. Over the past decade, private equity (PE) firms have aggressively acquired stakes in home health and hospice agencies. Regulators have expressed profound concern that the "short-term profit" model often associated with PE ownership may conflict with the clinical mandates of end-of-life and home-based care.
The CMS is particularly wary of rapid, successive changes in ownership, which are frequently used to obfuscate the identities of true stakeholders. These frequent shifts can create "holes" in oversight, allowing operators to move assets and billing privileges before regulators can perform a thorough audit. Under the current moratorium, the agency has restricted reenrollment for agencies following a change in majority ownership, effectively closing a loophole that bad actors have historically exploited to circumvent regulatory scrutiny.
Chronology: From Initial Pause to Current Policy
The path to this extended moratorium reflects a multi-year escalation in the government’s battle against healthcare waste and abuse.
- May 2026: The CMS implements the initial national moratorium on new home health and hospice enrollments, citing an urgent need to stop a spike in fraudulent activity.
- October 2026: A targeted enforcement operation in California sends shockwaves through the industry. The two-day sweep results in 145 providers being stripped of their Medicare billing privileges, demonstrating the scale of the infiltration.
- Early November 2026: The CMS finalizes a sweeping new rule that ties Medicare billing privileges directly to the conduct of owners and managers. This rule grants the agency the authority to revoke enrollment retroactively and across all provider types if owners are found to be involved in fraud.
- November 13, 2026: The CMS formally announces the six-month extension of the enrollment freeze, while simultaneously softening the blow for legitimate providers by allowing the expansion of existing service locations.
Implications for the Industry and Patient Care
The extension carries significant weight for the post-acute care industry. For established, reputable agencies, the ability to open new practice locations is a welcome relief. Many industry groups argued that the original, blanket ban threatened to leave "care deserts"—geographic areas where patient demand for home health services far outweighs supply.
The Balancing Act
The National Alliance for Care at Home, while generally supportive of the government’s efforts to purge fraud from the market, has been a vocal critic of the broad nature of the moratorium. In a statement released following the extension, the Alliance welcomed the modification, noting that allowing existing, high-performing agencies to expand is a common-sense approach that ensures beneficiaries are not negatively impacted by the regulatory crackdown.
"The goal should be to protect the Medicare trust fund without penalizing providers who are legitimately meeting the needs of their communities," a spokesperson for the Alliance noted. By narrowing the scope, the CMS is acknowledging that while fraud is a systemic issue, it should not be treated with a blunt instrument that hinders legitimate clinical operations.
Strengthening the Legal Framework: The New Final Rule
The extension of the moratorium does not exist in a vacuum; it is part of a broader, more aggressive regulatory architecture. The final rule issued earlier this month is perhaps the most significant legal development for Medicare oversight in recent years.
By broadening the agency’s authority to revoke enrollments based on the conduct of managing organizations—and extending that authority to include providers who land in trouble with other programs like Medicaid—the CMS is building a "blacklist" that is harder for fraudulent operators to escape. If an owner is caught running a fraudulent hospice in one state, they can no longer simply shutter that business and open a home health agency in another state under a different name.
The retroactive nature of these revocations also allows the CMS to recover improper payments more effectively. This creates a powerful financial deterrent, as bad actors now face the prospect of losing not just their future billing privileges, but also the revenue they have already collected through illicit means.
Supporting Data and the Path Forward
The necessity of these measures is underscored by the sheer volume of Medicare spending in the post-acute sector. Home health and hospice represent billions of dollars in annual federal spending. Even a small percentage of fraudulent billing results in massive losses for the taxpayer.
While the CMS has not released an exact dollar figure on how much the moratorium has saved the program, the removal of 145 providers in the California sweep alone indicates that the "leakage" in the system is substantial.
As we look toward June 2027, the success of these measures will likely be measured by:
- Reduction in Improper Payments: Whether the rate of "pay and chase" recovery efforts decreases.
- Market Stabilization: Whether the consolidation of the market leads to higher quality, more consistent care, or if it creates unintended barriers for smaller, community-based providers.
- Fraud Detection Efficacy: Whether the fingerprinting and enhanced screening processes prove effective at stopping bad actors at the application door, rather than months or years down the line.
The CMS is clearly signaling that the era of "easy entry" into the Medicare home health and hospice market is over. For those operating within the law, this period represents a transition toward a more regulated, transparent, and scrutinized environment. For those attempting to exploit the system, the tightening of the regulatory net makes the cost of doing business significantly higher, and the risk of detection—and subsequent exclusion—more imminent than ever before.
As the industry navigates the next six months, all eyes will be on the CMS to see if this targeted, data-driven approach will finally succeed in isolating fraudulent activity without stifling the essential, life-sustaining services that millions of Medicare beneficiaries rely on every day.
